Skip to Main Content

Paper Details

Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.
Ophthalmology
206
2019
Author NameAffiliation
Robyn H GuymerRoyal Victorian Eye and Ear Hospital, University of Melbourne
Ian L McAllisterLions Eye Institute, University of Western Australia
Mark C GilliesSave Sight Institute, The University of Sydney, Sydney Eye Hospital
  • 1 - 3

Datasets

Release 1.2